Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-08-011275
Filing Date
2008-12-16
Accepted
2008-12-16 14:29:36
Documents
1
Period of Report
2008-12-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4529
  Complete submission text file 0001127602-08-011275.txt   6381
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS INC 58 S SERVICE RD MELVILLE NY 11747
Business Address
AMPER LINDA E (Reporting) CIK: 0001220024 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 081252074